Episode
Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.
- Podcast
- Answers from the Lab
- Published
- Oct 16, 2025
- Duration seconds
- 952
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/e9089f31
Actions
POST https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/answers-from-the-lab-870296/developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Published October 16, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments. Together, they explore: FDA rescinds rule on LDTs (00:48): The FDA has officially withdrawn its rule that would allow oversight of laboratory-developed tests (LDTs) as medical devices. The conversation explores what this decision means and what might come next for LDT regulation. PAMA reform update and new RESULTS Act (05:13): The newly introduced Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act aims to address reimbursement for laboratory tests. Getting engaged (12:37): Why it is important to understand new regulatory policies and help others understand their implications for the industry. Resources Find past “Answers From the Lab” podcasts on LDTs and PAMA